AlphaYouOM
Insider buying
Opaleye Management Inc. bought $24K of Grace Therapeutics, Inc. (GRCE) stock
Opaleye Management Inc., 10% owner of Grace Therapeutics, Inc. (GRCE), bought 11,608 shares of GRCE stock worth $24K, per an SEC Form 4 filed Aug 19, 2026.
It was an open-market purchase.
The trade happened on Aug 14, 2026, 5 days before it was made public.
GRCE has moved -2.8% since the trade date, from $2.16 to $2.10 (Sep 21, 2026 close).
- Traded
- Aug 14, 2026
- Disclosed
- Aug 19, 2026
- Filing delay
- 5 days
- Price since
- -2.8%
- Role
- 10% owner
- Source
- SEC Form 4
More GRCE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.